Accretion Pharmaceuticals Ltd (ACCPL) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: ACCPL | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Accretion Pharmaceuticals Ltd (ACCPL) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: ACCPL | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Accretion Pharma.

Based on:

M-Cap below 100cr DeciZen not available

Accretion Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
14.41
Market Cap:
97.9 Cr.
52-wk low:
0
52-wk high:
0

Is Accretion Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Accretion Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Accretion Pharmaceuticals Ltd is a below average quality company.

2. Is Accretion Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Accretion Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Accretion Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Accretion Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Accretion Pharma.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Accretion Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'24Mar'25TTM
ROCE % 12.6%46.3%-
Value Creation
Index
-0.12.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 13.457.457
Sales YoY Gr.-329.8%-
Adj EPS 28.36.1
YoY Gr.-324.1%-
BVPS (₹) 7.218.716.4
Adj Net
Profit
1.56.87
Cash Flow from Ops. -11.55.8-
Debt/CF from Ops. -1.22.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA329.8%
Adj EPS NANANA324.1%
BVPSNANANA158.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'24Mar'25TTM
Return on
Equity %
2765.134.8
Op. Profit
Mgn %
19.220.7NAN
Net Profit
Mgn %
11.111.811.8
Debt to
Equity
2.50.9-
Working Cap
Days
01780
Cash Conv.
Cycle
01120

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.92

Return on Equity has declined versus last 3 years average to 34.80%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Accretion Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 6.1 -
TTM Sales (₹ Cr.) 57.4 -
BVPS (₹.) 16.4 -
Reserves (₹ Cr.) 7 -
P/BV 5.37 -
PE 14.41 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 97.9
Equity (₹ Cr.) 11.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Accretion Pharma.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Accretion Pharma. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Accretion Pharma.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25
Sales13.3557.38
Operating Expenses 10.7945.49
Manufacturing Costs0.230.85
Material Costs9.3739.91
Employee Cost 0.793.04
Other Costs 0.411.70
Operating Profit 2.5611.88
Operating Profit Margin (%) 19.2%20.7%
Other Income 0.050.09
Interest 0.401.44
Depreciation 0.220.77
Exceptional Items 00
Profit Before Tax 29.76
Tax 0.502.97
Profit After Tax 1.496.79
PAT Margin (%) 11.2%11.8%
Adjusted EPS (₹)2.08.3
Dividend Payout Ratio (%)0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25

Equity and Liabilities

Shareholders Fund 5.4915.29
Share Capital 48.17
Reserves 1.497.12
Minority Interest00
Debt11.0710.56
Long Term Debt6.911.17
Short Term Debt4.169.39
Trade Payables6.587.59
Others Liabilities 4.306.44
Total Liabilities 27.4439.87

Fixed Assets

Gross Block5.487.09
Accumulated Depreciation0.221
Net Fixed Assets 5.256.09
CWIP 00
Investments 00
Inventories14.4820.61
Trade Receivables5.8011.66
Cash Equivalents 0.090.05
Others Assets 1.811.46
Total Assets 27.4439.87

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25
Cash Flow From Operating Activity -11.515.75
PBT 29.76
Adjustment 0.622.21
Changes in Working Capital -14.92-4.37
Tax Paid 0.79-1.86
Cash Flow From Investing Activity -5.48-1.61
Capex -5.48-1.61
Net Investments 00
Others 00
Cash Flow From Financing Activity 17.08-4.18
Net Proceeds from Shares 43
Net Proceeds from Borrowing 13.48-5.74
Interest Paid -0.40-1.44
Dividend Paid 00
Others -0-0
Net Cash Flow 0.09-0.04

Finance Ratio

PARTICULARSMar'24Mar'25
Ratios
ROE (%)27.1865.39
ROCE (%)12.6246.33
Asset Turnover Ratio0.491.7
PAT to CFO Conversion(x)-7.720.85
Working Capital Days
Receivable Days15956
Inventory Days396112
Payable Days25665

Accretion Pharmaceuticals Ltd Stock News

Accretion Pharmaceuticals Ltd FAQs

The current trading price of Accretion Pharma. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Accretion Pharma. stood at ₹97.88.
The latest P/E ratio of Accretion Pharma. as of 31-Dec-1969 is 14.41.
The latest P/B ratio of Accretion Pharma. as of 31-Dec-1969 is 5.37.
The 52-week high of Accretion Pharma. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Accretion Pharma. is ₹57.38 ( Cr.) .

About Accretion Pharmaceuticals Ltd

In the year 2012, its Promoters Harshad Nanubhai Rathod, Vivek Ashok Kumar Patel, Mayur Popatlal Sojitra and Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of ‘Accretion Pharmaceuticals’ was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 (Partnership Act) in the name and style of ‘M/s Accretion Pharmaceuticals’, pursuant to a deed of partnership dated December 18, 2012. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of ‘Accretion Pharmaceuticals Limited’ and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, the company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on principle-to-principle basis with different marketers. Also, the company caters to multiple corporate clients on loan licence and/or contract manufacturing basis.

The company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by an experienced board of directors, and a professional and experienced management team with extensive experience in the pharmaceutical.

Business area of the company

Accretion Pharmaceuticals is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.

Products of the company

Tablet

  • Antibiotic, Antibacterial, Antifungal
  • Anti- Inflammatory
  • Antihistamine, Antiallergics, Antitussives, Anticold.
  • Antiulcer and Antacid
  • Anti-Diabetic
  • Cardiac and Anti-Hypertensive
  • Psychotropic
  • Vitamins and Supplement

Capsule

  • Antibacterial, Antifungal
  • Anti- Inflammatory
  • Antiulcer and Antacid
  • Cardiac and Anti-Hypertensive
  • Vitamins and Supplement

External preparation

  • Antibiotic, Antibacterial, Antifungal
  • Anti-Inflammatory
  • Antipruritic
  • Anti-ulcer
  • Antiseptic

Oral powder

  • Antibiotic, Antibacterial, Antifungal
  • Antihistamine, Antiallergics, Antitussives, Anticold
  • Antiulcer and Antacid
  • Vitamins and Supplement

Oral liquid

  • Antibiotic, Antibacterial
  • Antihistamine, Antiallergics, Antitussives, Anticold.
  • Antiulcer and Antacid
  • Vitamins and Supplement
  • Antiparasitic, Antiemetic
  • Laxative

Awards, accreditations or recognitions

  • 2020: Received Indian Achievers Award for Emerging Company in Recognition of Outstanding Professional Achievements & Contribution in Nation Building.
  • 2023: Obtained ISO Certification 9001:2015 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.
  • 2023: Obtained ISO Certification 14001:2015 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.
  • 2023: Obtained ISO Certification 22000:2018 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.

History and milestones

  • December 18, 2012: Formed as a Partnership Firm in the name and style of ‘M/s Accretion pharmaceuticals’, pursuant to a deed of partnership dated December 18, 2012.
  • November 29, 2023: Incorporation of the Company ‘Accretion Pharmaceuticals Limited” as a Public Limited Company from conversion of ‘M/s Accretion Pharmaceuticals’ a Partnership firm vide partner’s resolution dated October 16, 2023.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×